AURKA and urinary bladder carcinoma: These preclinical observations were validated on several non-overlapping cohorts comprised of 693 human bladder cancers using tissue microarray and two genomically profiled sample sets which showed that there is a unique subset of bladder cancers with overexpression of AURKA and downregulation of NNMT characterized by aggressive behavior.